Active substance
Amino acids
- SFDA 1
- US FDA 54
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Aminoplasmal paed | 10 % | Solution for infusion · Intravenous use | 12 Bag | SAR 721.05 | Generic · Prescription | B. BRAUN | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TROPHAMINE | 6% (6GM/100ML) | injectable · injection | B BRAUN | Prescription | 20 Jul 1984 |
| TROPHAMINE 10% | 10% (10GM/100ML) | injectable · injection | B BRAUN | Prescription | 20 Jul 1984 |
| TRAVASOL 5.5% IN PLASTIC CONTAINER | 5.5% (5.5GM/100ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Aug 1984 |
| TRAVASOL 8.5% IN PLASTIC CONTAINER | 8.5% (8.5GM/100ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Aug 1984 |
| TRAVASOL 10% IN PLASTIC CONTAINER | 10% (10MG/100ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Aug 1984 |
| AMINOSYN-PF 7% | 7% (7GM/100ML) | injectable · injection | OTSUKA ICU MEDCL | Prescription | 6 Sep 1985 |
| AMINOSYN-PF 10% | 10% (10GM/100ML) | injectable · injection | OTSUKA ICU MEDCL | Prescription | 17 Oct 1986 |
| AMINOSYN II 10% IN PLASTIC CONTAINER | 10% (10GM/100ML) | injectable · injection | OTSUKA ICU MEDCL | Prescription | 19 Dec 1991 |
| AMINOSYN II 15% IN PLASTIC CONTAINER | 15% (15GM/100ML) | injectable · injection | OTSUKA ICU MEDCL | Prescription | 19 Dec 1991 |
| CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER | 15% (15GM/100ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 30 Aug 1996 |
| PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER | 20% (20GM/100ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 26 Aug 1998 |
| PREMASOL 6% IN PLASTIC CONTAINER | 6% (6GM/100ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 19 Jun 2003 |
| PREMASOL 10% IN PLASTIC CONTAINER | 10% (10GM/100ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 19 Jun 2003 |
| AMINO ACIDS | 15%(150GM/1000ML); 15%(300GM/2000ML) | injectable · injection | B BRAUN | Prescription | 13 Apr 2012 |
| FREAMINE 8.5% | 8.5% (8.5GM/100ML) | injectable · injection | B BRAUN | Discontinued | 24 Sep 1971 |
| FREAMINE II 8.5% | 8.5% (8.5GM/100ML) | injectable · injection | B BRAUN | Discontinued | 24 Sep 1971 |
| FREAMINE III 8.5% | 8.5% (8.5GM/100ML) | injectable · injection | B BRAUN | Discontinued | 24 Sep 1971 |
| FREAMINE III 10% | 10% (10GM/100ML) | injectable · injection | B BRAUN | Discontinued | 24 Sep 1971 |
| FREAMINE HBC 6.9% | 6.9% (6.9GM/100ML) | injectable · injection | B BRAUN | Discontinued | 24 Sep 1971 |
| AMINOSYN 5% | 5% (5GM/100ML) | injectable · injection | ICU MEDICAL INC | Discontinued | 3 Dec 1975 |
| AMINOSYN 7% | 7% (7GM/100ML) | injectable · injection | ICU MEDICAL INC | Discontinued | 3 Dec 1975 |
| AMINOSYN 10% | 10% (10GM/100ML) | injectable · injection | ICU MEDICAL INC | Discontinued | 3 Dec 1975 |
| AMINOSYN 8.5% | 8.5% (8.5GM/100ML) | injectable · injection | ICU MEDICAL INC | Discontinued | 3 Dec 1975 |
| AMINOSYN 7% (PH6) | 7% (7GM/100ML) | injectable · injection | ICU MEDICAL INC | Discontinued | 3 Dec 1975 |
| AMINOSYN 8.5% (PH6) | 8.5% (8.5GM/100ML) | injectable · injection | ICU MEDICAL INC | Discontinued | 3 Dec 1975 |
29 more — full table
Safety signals and safety-related labeling changes
- US FDA 24 Jul 2025 KABIVEN IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 24 Jul 2025 PERIKABIVEN IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Amino acids
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.